Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Gevaert

Showing results (81-90 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Allergy and Clinical Immunology|May 11, 2010
Oral steroids and doxycycline: two different approaches to treat nasal polypsThibaut Van Zele, Philippe Gevaert, Gabriele Holtappels, et al.
Clinical & Translational Immunology|February 1, 2023
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polypsPhilippe Gevaert, Stella E Lee, Russell A Settipane, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2008
T-cell regulation in chronic paranasal sinus diseaseNicholas Van Bruaene, Claudina Angela Pérez-Novo, Tomasz M Basinski, et al.
International Forum of Allergy & Rhinology|June 22, 2023
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-upMartin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2021
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal PolypsAnju T Peters, Joseph K Han, Peter Hellings, et al.
The Journal of Allergy and Clinical Immunology|November 23, 2020
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and managementClaus Bachert, Joe K Han, Martin Wagenmann, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2023
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti-IL-5 Biologic TherapyClaus Bachert, Amber U Luong, Philippe Gevaert, et al.
American Journal of Rhinology & Allergy|October 6, 2020
Surgery in Nasal Polyp Patients: Outcome After a Minimum Observation of 10 YearsStephan Vlaminck, Frederic Acke, Emmanuel Prokopakis, et al.
The Journal of Allergy and Clinical Immunology|June 12, 2020
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trialsPhilippe Gevaert, Theodore A Omachi, Jonathan Corren, et al.
The World Allergy Organization Journal|January 16, 2024
Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trialOliver Pfaar, Frédéric De Blay, Giorgio Walter Canonica, et al.
Pageof 15

Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Allergy and Clinical Immunology|May 11, 2010
Oral steroids and doxycycline: two different approaches to treat nasal polypsThibaut Van Zele, Philippe Gevaert, Gabriele Holtappels, et al.
Clinical & Translational Immunology|February 1, 2023
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polypsPhilippe Gevaert, Stella E Lee, Russell A Settipane, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2008
T-cell regulation in chronic paranasal sinus diseaseNicholas Van Bruaene, Claudina Angela Pérez-Novo, Tomasz M Basinski, et al.
International Forum of Allergy & Rhinology|June 22, 2023
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-upMartin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2021
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal PolypsAnju T Peters, Joseph K Han, Peter Hellings, et al.
The Journal of Allergy and Clinical Immunology|November 23, 2020
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and managementClaus Bachert, Joe K Han, Martin Wagenmann, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2023
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti-IL-5 Biologic TherapyClaus Bachert, Amber U Luong, Philippe Gevaert, et al.
American Journal of Rhinology & Allergy|October 6, 2020
Surgery in Nasal Polyp Patients: Outcome After a Minimum Observation of 10 YearsStephan Vlaminck, Frederic Acke, Emmanuel Prokopakis, et al.
The Journal of Allergy and Clinical Immunology|June 12, 2020
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trialsPhilippe Gevaert, Theodore A Omachi, Jonathan Corren, et al.
The World Allergy Organization Journal|January 16, 2024
Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trialOliver Pfaar, Frédéric De Blay, Giorgio Walter Canonica, et al.
Pageof 15